Target intelligence / Profile preview

MicroRNA expression regulatory machinery

Molecular classification
Other (complex of nucleic acid regulatory enzymes and binding proteins)
01

Overview

The microRNA expression regulatory machinery is a network of proteins and complexes responsible for the biogenesis, processing, maturation, and functional deployment of microRNAs (miRNAs). Key steps include transcription of primary miRNAs, nuclear processing by the Drosha-DGCR8 complex, nuclear export by Exportin-5, cytoplasmic processing by Dicer, and the assembly of the RNA-induced silencing complex (RISC) containing Argonaute proteins. This machinery determines the levels and activity of miRNAs, which regulate gene expression post-transcriptionally by targeting mRNAs for degradation or translational repression. Dysregulation of this machinery has been implicated in cancer, cardiovascular diseases, inflammation, and other conditions, making its components potential therapeutic targets. However, because "miRNA expression regulatory machinery" describes a system rather than a single molecule, it is not a canonical target; instead, drug discovery typically focuses on individual core components such as Dicer, Drosha, or Argonaute.

Other names
miRNA biogenesis machinerymicroRNA processing complexmicroRNA pathwaymicroRNA machinery
02

Mechanism of action

Modulation of miRNA biogenesis or processing (e.g., inhibiting or activating specific steps such as processing by Drosha or Dicer); altering miRNA-mediated gene silencing or activation.

03

Biological functions

Gene expression regulationmRNA degradationTranslational repressionCell proliferationCell differentiationCell deathSignal transduction
04

Disease associations

CancerCardiovascular diseaseInflammationNeurodegenerative diseaseInfection
05

Safety considerations

Off-target effects due to broad changes in gene regulationPotential long-term or systemic effects due to disruption of homeostatic gene expression
06

Interacting drugs

No approved drugs directly target the whole machinery, but modulators or inhibitors of individual components (such as Dicer, Drosha, or Argonaute inhibitors) are under investigation.
07

Biomarkers

Dysregulated miRNA expression profiles in body fluids (circulating miRNAs are widely studied as biomarkers for cancers and other diseases)

Beyond the preview

Go deeper on MicroRNA expression regulatory machinery.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA expression regulatory machinery.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call